PERIPHERAL BLOOD METHYLATION PROFILES ARE STRONG PREDICTORS OF RESPONSE AND NON-RESPONSE TO INFLIXIMAB AND VEDOLIZUMAB IN CROHN'S DISEASE

Vincent Joustra    

Conference
UEG Week 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing